Slowing Parkinson's disease progression: recent dopamine agonist trials.
Identifieur interne : 000069 ( Ncbi/Curation ); précédent : 000068; suivant : 000070Slowing Parkinson's disease progression: recent dopamine agonist trials.
Auteurs : Tianhong Pan ; Weidong Le ; Joseph Jankovic [États-Unis]Source :
- Neurology ; 2004.
English descriptors
- KwdEn :
- Antiparkinson Agents (pharmacology), Antiparkinson Agents (therapeutic use), Benzothiazoles, Biological Transport (drug effects), Cell Line, Tumor (drug effects), Clinical Trials as Topic, Dopamine (metabolism), Dopamine (pharmacology), Dopamine Agonists (pharmacology), Dopamine Agonists (therapeutic use), Dopamine Plasma Membrane Transport Proteins, Humans, In Vitro Techniques, Indoles (pharmacology), Indoles (therapeutic use), Levodopa (pharmacology), Levodopa (therapeutic use), Membrane Glycoproteins (metabolism), Membrane Transport Proteins (metabolism), Nerve Tissue Proteins (metabolism), Neuroblastoma (pathology), Parkinson Disease (drug therapy), Thiazoles (pharmacology), Thiazoles (therapeutic use).
- MESH :
- chemical , metabolism : Dopamine, Membrane Glycoproteins, Membrane Transport Proteins, Nerve Tissue Proteins.
- chemical , pharmacology : Antiparkinson Agents, Dopamine, Dopamine Agonists, Indoles, Levodopa, Thiazoles.
- chemical , therapeutic use : Antiparkinson Agents, Dopamine Agonists, Indoles, Levodopa, Thiazoles.
- chemical : Benzothiazoles, Dopamine Plasma Membrane Transport Proteins.
- drug effects : Biological Transport, Cell Line, Tumor.
- drug therapy : Parkinson Disease.
- pathology : Neuroblastoma.
- Clinical Trials as Topic, Humans, In Vitro Techniques.
PubMed: 14750218
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000211
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000211
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000202
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000069
Links to Exploration step
pubmed:14750218Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Slowing Parkinson's disease progression: recent dopamine agonist trials.</title>
<author><name sortKey="Pan, Tianhong" sort="Pan, Tianhong" uniqKey="Pan T" first="Tianhong" last="Pan">Tianhong Pan</name>
</author>
<author><name sortKey="Le, Weidong" sort="Le, Weidong" uniqKey="Le W" first="Weidong" last="Le">Weidong Le</name>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation><country>États-Unis</country>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:14750218</idno>
<idno type="pmid">14750218</idno>
<idno type="wicri:Area/PubMed/Corpus">000211</idno>
<idno type="wicri:Area/PubMed/Curation">000211</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000202</idno>
<idno type="wicri:Area/Ncbi/Merge">000069</idno>
<idno type="wicri:Area/Ncbi/Curation">000069</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Slowing Parkinson's disease progression: recent dopamine agonist trials.</title>
<author><name sortKey="Pan, Tianhong" sort="Pan, Tianhong" uniqKey="Pan T" first="Tianhong" last="Pan">Tianhong Pan</name>
</author>
<author><name sortKey="Le, Weidong" sort="Le, Weidong" uniqKey="Le W" first="Weidong" last="Le">Weidong Le</name>
</author>
<author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation><country>États-Unis</country>
<placeName><settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">Neurology</title>
<idno type="e-ISSN">1526-632X</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (pharmacology)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Benzothiazoles</term>
<term>Biological Transport (drug effects)</term>
<term>Cell Line, Tumor (drug effects)</term>
<term>Clinical Trials as Topic</term>
<term>Dopamine (metabolism)</term>
<term>Dopamine (pharmacology)</term>
<term>Dopamine Agonists (pharmacology)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
<term>Humans</term>
<term>In Vitro Techniques</term>
<term>Indoles (pharmacology)</term>
<term>Indoles (therapeutic use)</term>
<term>Levodopa (pharmacology)</term>
<term>Levodopa (therapeutic use)</term>
<term>Membrane Glycoproteins (metabolism)</term>
<term>Membrane Transport Proteins (metabolism)</term>
<term>Nerve Tissue Proteins (metabolism)</term>
<term>Neuroblastoma (pathology)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Thiazoles (pharmacology)</term>
<term>Thiazoles (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Dopamine</term>
<term>Membrane Glycoproteins</term>
<term>Membrane Transport Proteins</term>
<term>Nerve Tissue Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Dopamine</term>
<term>Dopamine Agonists</term>
<term>Indoles</term>
<term>Levodopa</term>
<term>Thiazoles</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Dopamine Agonists</term>
<term>Indoles</term>
<term>Levodopa</term>
<term>Thiazoles</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Benzothiazoles</term>
<term>Dopamine Plasma Membrane Transport Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Biological Transport</term>
<term>Cell Line, Tumor</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Neuroblastoma</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Clinical Trials as Topic</term>
<term>Humans</term>
<term>In Vitro Techniques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000069 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000069 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= JankovicV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:14750218 |texte= Slowing Parkinson's disease progression: recent dopamine agonist trials. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:14750218" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a JankovicV1
This area was generated with Dilib version V0.6.19. |